{"id":"https://openalex.org/W2067052513","doi":"https://doi.org/10.1097/00002030-200402200-00016","title":"HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1","display_name":"HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1","publication_year":2004,"publication_date":"2004-02-01","ids":{"openalex":"https://openalex.org/W2067052513","doi":"https://doi.org/10.1097/00002030-200402200-00016","mag":"2067052513","pmid":"https://pubmed.ncbi.nlm.nih.gov/15090802"},"language":"en","primary_location":{"id":"doi:10.1097/00002030-200402200-00016","doi":"https://doi.org/10.1097/00002030-200402200-00016","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200402200-00016","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112146489","display_name":"Danuta Pieni\u0105\u017cek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210113904","display_name":"National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention","ror":"https://ror.org/01wjn2x92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210113904"]},{"id":"https://openalex.org/I4210160401","display_name":"National Center for Infectious Diseases","ror":"https://ror.org/04vmke174","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210121439","https://openalex.org/I4210160401"]}],"countries":["ES","US"],"is_corresponding":true,"raw_author_name":"Danuta Pieniazek","raw_affiliation_strings":["HIV and Retrovirology Branch and the Office of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, USA","From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV and Retrovirology Branch and the Office of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I4210113904","https://openalex.org/I4210160401"]},{"raw_affiliation_string":"From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110267052","display_name":"Mark A. Rayfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210113904","display_name":"National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention","ror":"https://ror.org/01wjn2x92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210113904"]},{"id":"https://openalex.org/I4210160401","display_name":"National Center for Infectious Diseases","ror":"https://ror.org/04vmke174","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210121439","https://openalex.org/I4210160401"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Mark Rayfield","raw_affiliation_strings":["to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","institution_ids":[]},{"raw_affiliation_string":"From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037637926","display_name":"Dale J. Hu","orcid":"https://orcid.org/0000-0002-0519-1032","observed_orcids":["https://orcid.org/0000-0002-0519-1032"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210113904","display_name":"National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention","ror":"https://ror.org/01wjn2x92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210113904"]},{"id":"https://openalex.org/I4210160401","display_name":"National Center for Infectious Diseases","ror":"https://ror.org/04vmke174","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210121439","https://openalex.org/I4210160401"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Dale J Hu","raw_affiliation_strings":["to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","institution_ids":[]},{"raw_affiliation_string":"From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067498464","display_name":"John N. Nkengasong","orcid":"https://orcid.org/0000-0001-6047-0184","observed_orcids":["https://orcid.org/0000-0001-6047-0184"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210113904","display_name":"National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention","ror":"https://ror.org/01wjn2x92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210113904"]},{"id":"https://openalex.org/I4210160401","display_name":"National Center for Infectious Diseases","ror":"https://ror.org/04vmke174","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210121439","https://openalex.org/I4210160401"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"John N Nkengasong","raw_affiliation_strings":["to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","institution_ids":[]},{"raw_affiliation_string":"From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009751300","display_name":"Vincent Soriano","orcid":"https://orcid.org/0000-0002-4624-5199","observed_orcids":["https://orcid.org/0000-0002-4624-5199"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210113904","display_name":"National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention","ror":"https://ror.org/01wjn2x92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210113904"]},{"id":"https://openalex.org/I4210160401","display_name":"National Center for Infectious Diseases","ror":"https://ror.org/04vmke174","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210121439","https://openalex.org/I4210160401"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Vincent Soriano","raw_affiliation_strings":["to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","institution_ids":[]},{"raw_affiliation_string":"From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031077639","display_name":"Walid Heneine","orcid":"https://orcid.org/0000-0003-3119-3565","observed_orcids":["https://orcid.org/0000-0003-3119-3565"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210113904","display_name":"National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention","ror":"https://ror.org/01wjn2x92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210113904"]},{"id":"https://openalex.org/I4210160401","display_name":"National Center for Infectious Diseases","ror":"https://ror.org/04vmke174","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210121439","https://openalex.org/I4210160401"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Walid Heneine","raw_affiliation_strings":["to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","institution_ids":[]},{"raw_affiliation_string":"From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078706099","display_name":"Clement E. Zeh","orcid":"https://orcid.org/0000-0002-5023-0336","observed_orcids":["https://orcid.org/0000-0002-5023-0336"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210113904","display_name":"National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention","ror":"https://ror.org/01wjn2x92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210113904"]},{"id":"https://openalex.org/I4210160401","display_name":"National Center for Infectious Diseases","ror":"https://ror.org/04vmke174","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210121439","https://openalex.org/I4210160401"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Clement Zeh","raw_affiliation_strings":["to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","institution_ids":[]},{"raw_affiliation_string":"From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108727942","display_name":"Simon M. Agwale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210113904","display_name":"National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention","ror":"https://ror.org/01wjn2x92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210113904"]},{"id":"https://openalex.org/I4210160401","display_name":"National Center for Infectious Diseases","ror":"https://ror.org/04vmke174","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210121439","https://openalex.org/I4210160401"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Simon M Agwale","raw_affiliation_strings":["to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","institution_ids":[]},{"raw_affiliation_string":"From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110404700","display_name":"Charles O. Wambebe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210113904","display_name":"National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention","ror":"https://ror.org/01wjn2x92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210113904"]},{"id":"https://openalex.org/I4210160401","display_name":"National Center for Infectious Diseases","ror":"https://ror.org/04vmke174","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210121439","https://openalex.org/I4210160401"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Charles Wambebe","raw_affiliation_strings":["to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","institution_ids":[]},{"raw_affiliation_string":"From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008928325","display_name":"Lilian Odama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210113904","display_name":"National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention","ror":"https://ror.org/01wjn2x92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210113904"]},{"id":"https://openalex.org/I4210160401","display_name":"National Center for Infectious Diseases","ror":"https://ror.org/04vmke174","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210121439","https://openalex.org/I4210160401"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Liliana Odama","raw_affiliation_strings":["to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","institution_ids":[]},{"raw_affiliation_string":"From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031275760","display_name":"Stefan Z. Wiktor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210113904","display_name":"National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention","ror":"https://ror.org/01wjn2x92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210113904"]},{"id":"https://openalex.org/I4210160401","display_name":"National Center for Infectious Diseases","ror":"https://ror.org/04vmke174","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210109567","https://openalex.org/I4210121439","https://openalex.org/I4210160401"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Stefan Z Wiktor","raw_affiliation_strings":["to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"to D. Pieniazek, 1600 Clifton Road, Mail Stop G19, Atlanta, GA 30333, USA","institution_ids":[]},{"raw_affiliation_string":"From the HIV and Retrovirology Branch and the aOffice of the Director, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Atlanta, Georgia, and the bDivision of HIV/AIDS Prevention and cProjet RETRO-CI, Ivory Coast, the dInstituto de Salud Carlos III, Madrid, Spain, the eNational Institute of Pharmaceutical Research and Development and the fFederal Ministry of Health, Abuja, Nigeria, and the gGlobal AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5112146489"],"corresponding_institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I2801357902","https://openalex.org/I4210113904","https://openalex.org/I4210160401"],"apc_list":null,"apc_paid":null,"fwci":3.7905,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.9295387,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"18","issue":"3","first_page":"495","last_page":"502"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-2","display_name":"HIV-2","score":0.9660000205039978},{"id":"https://openalex.org/keywords/hiv-1-protease","display_name":"HIV-1 protease","score":0.8500000238418579},{"id":"https://openalex.org/keywords/protease-inhibitor-resistance","display_name":"protease inhibitor resistance","score":0.8889999985694885},{"id":"https://openalex.org/keywords/resistance-associated-mutations","display_name":"resistance-associated mutations","score":0.8330000042915344},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.5879999995231628},{"id":"https://openalex.org/keywords/hiv-2-infection","display_name":"HIV-2 infection","score":0.39500001072883606},{"id":"https://openalex.org/keywords/codon-substitution","display_name":"codon substitution","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.6909064054489136},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.6428179144859314},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6068992018699646},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.596172571182251},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.5320654511451721},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.5022299289703369},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.47950559854507446},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.44131675362586975},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.44126832485198975},{"id":"https://openalex.org/C2777583353","wikidata":"https://www.wikidata.org/wiki/Q410261","display_name":"HIV-1 protease","level":4,"score":0.43536460399627686},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.4347706437110901},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.41516441106796265},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3822008967399597},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.22558468580245972},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.21120211482048035},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.1738245189189911},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1546764373779297},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004279","descriptor_name":"DNA, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010802","descriptor_name":"Phylogeny","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014644","descriptor_name":"Genetic Variation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015498","descriptor_name":"HIV-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D016282","descriptor_name":"Aspartic Acid Endopeptidases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016333","descriptor_name":"HIV Protease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002030-200402200-00016","doi":"https://doi.org/10.1097/00002030-200402200-00016","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200402200-00016","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:15090802","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15090802","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W970753441","https://openalex.org/W1493172229","https://openalex.org/W1576999979","https://openalex.org/W1952459954","https://openalex.org/W1967852766","https://openalex.org/W1995267885","https://openalex.org/W2003861249","https://openalex.org/W2009554536","https://openalex.org/W2018161360","https://openalex.org/W2035365163","https://openalex.org/W2035723968","https://openalex.org/W2036396592","https://openalex.org/W2037716012","https://openalex.org/W2049343837","https://openalex.org/W2053711547","https://openalex.org/W2061114508","https://openalex.org/W2061805840","https://openalex.org/W2064085246","https://openalex.org/W2075971959","https://openalex.org/W2079341971","https://openalex.org/W2092012373","https://openalex.org/W2123166384","https://openalex.org/W2129203591","https://openalex.org/W2159236259","https://openalex.org/W2168578033","https://openalex.org/W2169563423","https://openalex.org/W2176264043","https://openalex.org/W2331692122","https://openalex.org/W2334277624","https://openalex.org/W2396206058","https://openalex.org/W2409948472","https://openalex.org/W2914058108","https://openalex.org/W3199943451"],"related_works":["https://openalex.org/W2009554536","https://openalex.org/W2070588546","https://openalex.org/W2159236259","https://openalex.org/W2039234690","https://openalex.org/W7100165799","https://openalex.org/W2171088654","https://openalex.org/W2893286347","https://openalex.org/W3204943543","https://openalex.org/W2055637117","https://openalex.org/W2118330511"],"abstract_inverted_index":{"BACKGROUND:":[0],"HIV-1":[1,42],"protease":[2,53],"inhibitors":[3],"(PI)":[4],"have":[5],"been":[6],"used":[7],"for":[8],"treating":[9],"HIV-2-infected":[10,48],"persons":[11],"but":[12],"little":[13],"is":[14],"known":[15],"about":[16],"amino":[17,67],"acid":[18],"mutations":[19,45,116,143],"associated":[20],"with":[21,223],"PI":[22,43,167],"resistance":[23],"in":[24,34,46,119,134,251],"HIV-2":[25,80,252],"and":[26,64,73,87,122,130,137,148,175,191,206,233,257,260],"whether":[27],"they":[28],"are":[29,263],"similar":[30,118],"to":[31,69,84,89,265],"those":[32],"seen":[33],"HIV-1.":[35],"OBJECTIVE:":[36],"To":[37],"determine":[38,266],"the":[39,78,155,161,172,219,267],"frequency":[40,113,242],"of":[41,114,218,243,254,269],"resistance-associated":[44,168],"PI-naive":[47],"individuals.":[49],"DESIGN:":[50],"Using":[51],"PCR,":[52],"genes":[54],"were":[55,132,150],"amplified":[56],"from":[57],"76":[58,79,162],"individuals,":[59],"directly":[60],"sequenced,":[61],"phylogenetically":[62],"subtyped,":[63],"translated":[65],"into":[66],"acids":[68],"analyze":[70],"PI-associated":[71,245],"major":[72,126,173],"minor":[74,176,225],"mutations.":[75],"RESULTS:":[76],"Of":[77,160],"sequences,":[81],"68%":[82],"belonged":[83],"subtype":[85,90,120],"A":[86,121,256],"32%":[88],"B.":[91,258],"All":[92],"sequences":[93,220],"contained":[94],"at":[95,102],"least":[96],"four":[97],"codon":[98],"changes":[99],"giving":[100],"substitutions":[101,169,246],"10,":[103],"30,":[104],"32,":[105],"36,":[106],"46,":[107],"47,":[108],"71":[109],"or":[110],"77.":[111],"The":[112,215,240],"these":[115,270],"was":[117],"B":[123],"viruses.":[124],"Two":[125],"resistance-conferring":[127],"mutations,":[128],"30N":[129],"46I,":[131,181,188,195,202,211],"identified":[133],"one":[135],"(1%)":[136],"68":[138],"(89%)":[139],"specimens,":[140],"respectively.":[141],"Minor":[142],"10V/I,":[144,178],"32I,":[145,179,186,193,201,209,228,235],"36I,":[146,180,187,194,210,229,236],"47V,":[147,182,203,212,230],"71V":[149,183,204,213,231],"predominant":[151],"(89%-100%),":[152],"followed":[153],"by":[154],"rare":[156],"mutation":[157],"77I":[158,198],"(1%).":[159],"strains,":[163],"89%":[164],"harbored":[165],"multiple":[166,244],"comprising":[170],"both":[171],"46I":[174],"mutations:":[177,226],"(76%);":[184],"10V,":[185,192,200,207,227,234],"47V":[189,196,237],"(9%);":[190],"71V,":[197],"(1.3%),":[199,205],"30N,":[208],"(1.3%).":[214,238],"remaining":[216],"11%":[217],"had":[221],"patterns":[222],"only":[224],"(9%)":[232],"CONCLUSIONS:":[239],"high":[241],"represent":[247],"natural":[248],"polymorphisms":[249],"occurring":[250],"strains":[253],"subtypes":[255],"Phenotypic":[259],"clinical":[261],"studies":[262],"needed":[264],"relevance":[268],"substitutions.":[271]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}